Zinbryta
- Product NDC
- 0074-0034
- 11-digit product format
- 000740034
- Labeler code
- 0074
- Product ID
- 0074-0034_44238333-9880-413b-9a9e-1f2b09e0fd6a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daclizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Abbvie
- Application
- BLA761029
- Marketing category
- BLA
- Marketing start
- 2017-05-26
- Marketing end
- 2019-10-31
- Substance
- DACLIZUMAB
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Interleukin 2 Receptor Antagonists [MoA],Interleukin 2 Receptor-directed Antibody Interactions [MoA],Interleukin-2 Receptor Blocking Antibody [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record